Table 2.
JCV-positive |
JCV-negative |
||||
---|---|---|---|---|---|
Characteristic | n | % | n | % | p-value |
Sex | |||||
male | 266 | 70.0 | 114 | 30.0 | |
female | 341 | 72.2 | 131 | 27.8 | 0.48 |
Age (years) | |||||
< 35 | 30 | 83.3 | 6 | 16.7 | |
35–44 | 67 | 72.8 | 25 | 27.2 | |
45–54 | 173 | 70.9 | 71 | 29.1 | |
55–64 | 172 | 67.5 | 83 | 32.5 | |
65–74 | 123 | 73.2 | 45 | 26.8 | |
75+ | 34 | 69.4 | 15 | 30.6 | 0.09 |
Smoking status | |||||
current | 125 | 74.0 | 44 | 26.0 | 0.871 |
former | 156 | 65.5 | 82 | 34.5 | 0.031 |
never | 326 | 73.3 | 119 | 26.7 | |
Body mass index (kg/m2)2 | |||||
< 25 | 91 | 58.7 | 64 | 41.3 | |
25–30 | 81 | 49.4 | 83 | 50.6 | |
30+ | 25 | 41.0 | 36 | 59.0 | 0.05 |
NSAID use at baseline (past 48 hours)3 | |||||
yes | 174 | 28.7 | 64 | 26.1 | |
no | 433 | 74.3 | 181 | 73.9 | 0.45 |
Family history of colorectal cancer2 | |||||
no | 127 | 51.2 | 121 | 48.8 | |
yes | 22 | 52.4 | 20 | 47.6 | 1.00 |
Recent hormone use2 | |||||
none | 83 | 50.0 | 83 | 50.0 | |
any | 19 | 54.3 | 16 | 45.7 | 0.71 |
p-values correspond to comparison between current versus never smokers and former versus never smokers
data obtained from CLUE II participants only
NSAID use within 48 hours prior to blood draw